Search
for
Sort by
Research 181–210 of 1000+
- Exploring the Drug Repurposing Versatility of Valproic Acid as a Multifunctional Regulator of Innate and Adaptive Immune Cells
- 455 Molecular correlation with clinical outcomes in an open label clinical trial of oral tofacitinib in patients with alopecia areata
- Exploring Mast Cell–CD8 T Cell Interactions in Inflammatory Skin Diseases
- Multiple minute digitate hyperkeratosis
- Cutaneous toxicities of new targeted cancer therapies: must know for diagnosis, management, and patient-proxy empowerment
- Skin fragility, diffuse ecchymosis and blisters on a yellowish waxy base
- Cutaneous Neuroimmune Interactions in Peripheral Neuropathic Pain States
- Rare Cutaneous Side Effects of Imiquimod: A Review on Its Mechanisms, Diagnosis, and Management
- Lupus Erythematosus Profundus with Multiple Overlying Cutaneous Ulcerations: A Rare Case
- Cutaneous toxicity as a predictive biomarker for clinical outcome in patients receiving anticancer therapy
- 057 Single cell RNA and TCR sequencing reveals hyperexpansion of T cell clones and novel regulatory mechanisms of CD8+ T cells in murine alopcecia areata skin and draining lymph nodes
- General Dermatology
- British Society for Dermatopathology
- Proceedings of the Heinz Maurer-Symposium “Review and Preview in Science for Healthy Skin” June 28th 2014, Jakobsberg, Boppard, Germany
- Dermal T cell immunity and key regulatory signaling pathways: Implications in immune-mediated alopecia and hair regeneration
- Epidermal Stem Cells in Hair Follicle Cycling and Skin Regeneration: A View From the Perspective of Inflammation
- Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital
- Cutaneous immunopathology of androgenetic alopecia
- Areata-Like Lupus as a Clinical Manifestation of Cutaneous Lupus Erythematosus
- Prominent Cutaneous Manifestation of COVID-19: A Case Report
- LUPUS ERYTHEMATOSUS AND THE SKIN
- ADVANCES IN PSORIASIS THERAPY
- Cutaneous manifestations and considerations in COVID ‐19 pandemic: A systematic review
- Validation of the Cutaneous Lupus Disease Area and Severity Index (CLASI) using physician- and patient-assessed health outcome measures
- Mucocutaneous reactions to chemotherapy
- High-throughput T cell receptor sequencing identifies clonally expanded CD8+ T cell populations in alopecia areata
- Skin
- The Spectrum of Cutaneous Manifestations in Lupus Erythematosus: A Comprehensive Review
- CD123 immunohistochemistry for plasmacytoid dendritic cells is useful in the diagnosis of scarring alopecia
- Heterozygous FOXN1 Variants Cause Low TRECs and Severe T Cell Lymphopenia, Revealing a Crucial Role of FOXN1 in Supporting Early Thymopoiesis